| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 681279 | 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) | 0.0385613993886 | 0.50587806 |
| NSC 685981 | 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- | 0.0385613993886 | 0.21104664 |
| NSC 688814 | Null | 0.0385613993886 | -0.15858615 |
| NSC 734982 | Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate | 0.0385613993886 | -0.23021089 |
| NSC 741898 | 4-(2-pyridinyl)-5H-1,2,3-dithiazole-5-thione | 0.0385613993886 | 0.32241485 |
| NSC 756225 | GW410563A | 0.0385613993886 | -0.14554791 |
| NSC 762557 | Null | 0.0385613993886 | -0.11198594 |
| NSC 105014 | Cladribine | 0.0385613993886001 | 0.419707 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0385613993886001 | 0.39387764 |
| NSC 126728 | WLN: T B-18-56 C6 A 2BC D& AX CX EOV KOV QVO VO MU OU A&UTJ B1 GQH1 B&1 A-& BT3OX CHJ | 0.0385613993886001 | 0.32138213 |